Invesco S&P SmallCap Health Care ETF PSCH
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Expense ratio
- 0.29%
- Net assets
- $131.4M
- Holdings
- 81
- 12-month distribution yield
- Unavailable
- Asset class
- Equity
Invesco S&P SmallCap Health Care ETF (PSCH) is an exchange-traded fund listed on the Nasdaq in the United States, issued by Invesco. Its category is Equity · US (equity). Its last price was US$53.60 on 20 Oct 2026. Its expense ratio is 0.29% a year, from its prospectus dated 19 Dec 2025. It reported net assets of US$131.36 million as of 31 May 2026. Its latest holdings report lists 81 holdings as of 31 May 2026.
Fees
- Total annual operating expenses (gross)
- 0.29%
- Net, after fee waivers or reimbursements
- No waiver stated
- Management fee
- 0.29%
- Prospectus date
- 19 Dec 2025
- Filed with the SEC
- 18 Dec 2025
Size and reporting
- Net assets
- $131,359,966
- Total assets
- $170,466,655
- Holdings as of
- 31 May 2026
- Report made public
- 28 Jul 2026 (58 days after the month end)
Top holdings
Largest 25 of 81 positions, as of 31 May 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | Invesco Private Prime Fund | No identifier reported | 21.48% | $28.2M | Short-term investment vehicles (cash funds) | United States | USD |
| 2 | Invesco Private Government Fund | No identifier reported | 8.27% | $10.9M | Short-term investment vehicles (cash funds) | United States | USD |
| 3 | Molina Healthcare, Inc. | US60855R1005 | 4.77% | $6.3M | Equity (common) | United States | USD |
| 4 | BrightSpring Health Services, Inc. | US10950A1060 | 4.35% | $5.7M | Equity (common) | United States | USD |
| 5 | Krystal Biotech, Inc. | US5011471027 | 4.25% | $5.6M | Equity (common) | United States | USD |
| 6 | Alkermes PLC | IE00B56GVS15 | 3.71% | $4.9M | Equity (common) | Ireland | USD |
| 7 | Corcept Therapeutics Inc. | US2183521028 | 3.47% | $4.6M | Equity (common) | United States | USD |
| 8 | Glaukos Corp. | US3773221029 | 3.17% | $4.2M | Equity (common) | United States | USD |
| 9 | PTC Therapeutics, Inc. | US69366J2006 | 3.16% | $4.2M | Equity (common) | United States | USD |
| 10 | Protagonist Therapeutics, Inc. | US74366E1029 | 3.12% | $4.1M | Equity (common) | United States | USD |
| 11 | Teleflex Inc. | US8793691069 | 3.03% | $4.0M | Equity (common) | United States | USD |
| 12 | TG Therapeutics, Inc. | US88322Q1085 | 2.75% | $3.6M | Equity (common) | United States | USD |
| 13 | Ligand Pharmaceuticals Inc. | US53220K5048 | 2.43% | $3.2M | Equity (common) | United States | USD |
| 14 | Indivior Pharmaceuticals, Inc. | US45579U1097 | 2.40% | $3.2M | Equity (common) | United States | USD |
| 15 | RadNet, Inc. | US7504911022 | 2.06% | $2.7M | Equity (common) | United States | USD |
| 16 | Merit Medical Systems, Inc. | US5898891040 | 1.99% | $2.6M | Equity (common) | United States | USD |
| 17 | Veracyte, Inc. | US92337F1075 | 1.95% | $2.6M | Equity (common) | United States | USD |
| 18 | Catalyst Pharmaceuticals, Inc. | US14888U1016 | 1.92% | $2.5M | Equity (common) | United States | USD |
| 19 | Organon & Co. | US68622V1061 | 1.85% | $2.4M | Equity (common) | United States | USD |
| 20 | ICU Medical, Inc. | US44930G1076 | 1.78% | $2.3M | Equity (common) | United States | USD |
| 21 | Integer Holdings Corp. | US45826H1095 | 1.67% | $2.2M | Equity (common) | United States | USD |
| 22 | Concentra Group Holdings Parent, Inc. | US20603L1026 | 1.58% | $2.1M | Equity (common) | United States | USD |
| 23 | Acadia Pharmaceuticals Inc. | US0042251084 | 1.45% | $1.9M | Equity (common) | United States | USD |
| 24 | Supernus Pharmaceuticals, Inc. | US8684591089 | 1.41% | $1.9M | Equity (common) | United States | USD |
| 25 | Privia Health Group, Inc. | US74276R1023 | 1.33% | $1.7M | Equity (common) | United States | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 99.93% | |
| Short-term investment vehicles (cash funds) | 29.79% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 125.20% | |
| Ireland | 4.53% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 129.72% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 65.01% | |
| Health Technology | 1.92% | |
| Technology | 1.22% | |
| Finance | 1.03% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- Unavailable
- 12-month yield
- Unavailable
- Frequency
- Quarterly
- Latest ex-date
- 22 Sep 2025
12-month yield = distributions per unit with an ex-date in the last 12 months ÷ latest price × 100. It is not shown because there were no distributions in the last 12 months.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (7 payments)
| Ex-date | Amount per unit |
|---|---|
| 22 Sep 2025 | $0.0030 |
| 23 Jun 2025 | $0.0020 |
| 24 Mar 2025 | $0.0140 |
| 23 Dec 2024 | $0.0180 |
| 24 Jun 2024 | $0.0660 |
| 18 Mar 2024 | $0.0360 |
| 18 Dec 2023 | $0.0040 |
Filings and sources
- Form N-PORT report for May 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000028299) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- PSCH and VTI Vanguard Morningstar Total Stock Market ETF
- PSCH and VOO Vanguard S&P 500 ETF
- PSCH and IVV iShares Core S&P 500 ETF
- PSCH and QQQ Invesco QQQ Trust, Series 1